Skip to content

The Strategy of Implementation of the ERAS Protocol After Esophageal Surgery

The Strategy of Implementation of the ERAS Protocol After Esophageal Surgery Based on Innovative Technologies

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05311787
Enrollment
500
Registered
2022-04-05
Start date
2011-01-31
Completion date
2026-03-31
Last updated
2022-04-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ERAS, Esophageal Diseases

Brief summary

Application of the perioperative enhanced recovery protocol has allowed to carry out esophagectomy to the patients with severe comorbidities and has led reducing the risks of severe postoperative complications.

Detailed description

The clinical trial included the parients who participated in the protocol ERAS since 2011, who uderwent esophagectomy with simultaneous reconstruction. The parients had benign or malignant esophageal diseases. The ERAS protocol consisted of components of perioperative recovery. The number of patients until now has reached 400 patients. During trial there was modifications of aspects of ERAS protocol such as a rejection of nasogastric tube or cervical drenage. The role of multidisplinary team is the main success of the result of the implemented ERAS protocol.

Interventions

PROCEDUREesophagectomy with simultaneous reconstruction

Subtotal resection of esophagus and simultaneous reconstruction by gastric pull-up or colon conduit

Sponsors

Vishnevsky Center of Surgery
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

All the patients over 18 years old with esophageal diseases who are required surgical treatment include in trial.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* all patients with esophageal diseases

Exclusion criteria

* before 18 years old * who do not need surgery as a treatment * who not underwent simultaneous recontruction

Design outcomes

Primary

MeasureTime frameDescription
mortality30 daysthe rate of mortality after surgery
morbidity30 daysthe rate of morbidity after surgery

Countries

Russia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026